PAC-113: Phase IIb started

PGA began a single-blind, U.S. and South African Phase IIb trial (PBC002-01) in about 200 seropositive HIV patients with oral candidiasis to compare 3 doses of PAC-113 vs. nystatin oral suspension. ...